Panbela Therapeutics Inc (PBLA) stock has fallen -99.63% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives PBLA stock a score of 29 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 2. PBLA's rank also includes a short-term technical score of 9. PBLA has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on PBLA!